Fatal Hymenoptera Venom–Triggered Anaphylaxis in Patients with Unrecognized Clonal Mast Cell Disorder—Is Mastocytosis to Blame?
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms242216368 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Matija Rijavec und 7 weiteren Autor:innen. Beteiligte Einrichtung: University Clinic of Respiratory and Allergic Diseases Golnik, 4204 Golnik, Slovenia. Hauptthemen laut MEDLINE: Anaphylaxis, Arthropod Venoms, Hymenoptera, Mastocytosis. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Slovenian Research Agency, Slovenian Research and Innovation Agency.
Abstract (Originalsprache)
Hymenoptera venom–triggered anaphylaxis (HVA) affects up to 8.9% of the general population and is the most frequent cause of anaphylaxis in adults, accounting for approximately 20% of all fatal anaphylaxis cases. Quite often, a fatal reaction is a victim’s first manifestation of HVA. Mastocytosis represents one of the most important risk factors for severe HVA. We analyzed patients with documented fatal HVA for the presence of underlying clonal mast cell disorder (cMCD). Here, we report three cases of fatal HVA, with undiagnosed underlying cMCD identified by the presence of the peripheral blood and/or bone marrow KIT p.D816V missense variant postmortem. In the first case, anaphylaxis was the initial episode and was fatal. In the other two cases, both patients were treated with specific venom immunotherapy (VIT), nevertheless, one died of HVA after VIT discontinuation, and the other during VIT; both patients had cardiovascular comorbidities and were taking beta-blockers and/or ACE inhibitors. Our results point to the importance of screening all high-risk individuals for underlying cMCD using highly sensitive molecular methods for peripheral blood KIT p.D816V variant detection, including severe HVA and possibly beekeepers, for proper management and the need for lifelong VIT to prevent unnecessary deaths. Patients at the highest risk of fatal HVA, with concomitant cardiovascular and cMCD comorbidities, might not be protected from field stings even during regular VIT. Therefore, two adrenaline autoinjectors and lifelong VIT, and possibly cotreatment with omalizumab, should be considered for high-risk patients to prevent fatal HVA episodes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University Clinic of Respiratory and Allergic Diseases Golnik, 4204 Golnik, Slovenia.
- Biotechnical Faculty, University of Ljubljana, 1000 Ljubljana, Slovenia.
- Institute of Forensic Medicine, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.
- National Institute of Public Health, 1000 Ljubljana, Slovenia.
- Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.
- Faculty of Pharmacy, University of Ljubljana, 1000 Ljubljana, Slovenia.
ORCID-Profile: Matija Rijavec, Urška Bidovec-Stojković, Mitja Košnik
Förderung
- Slovenian Research Agency
- Slovenian Research and Innovation Agency
Zitieren
APA
Rijavec, M., Inkret, J., Bidovec-Stojković, U., Carli, T., Frelih, N., Kukec, A., Korošec, P., & Košnik, M. (2023). Fatal Hymenoptera Venom–Triggered Anaphylaxis in Patients with Unrecognized Clonal Mast Cell Disorder—Is Mastocytosis to Blame?. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242216368
Vancouver
Rijavec M, Inkret J, Bidovec-Stojković U, Carli T, Frelih N, Kukec A, et al. Fatal Hymenoptera Venom–Triggered Anaphylaxis in Patients with Unrecognized Clonal Mast Cell Disorder—Is Mastocytosis to Blame?. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242216368
BibTeX
@article{Rijavec2023,
author = {Rijavec, Matija and Inkret, Jezerka and Bidovec-Stojković, Urška and Carli, Tanja and Frelih, Nina and Kukec, Andreja and Korošec, Peter and Košnik, Mitja},
title = {Fatal Hymenoptera Venom–Triggered Anaphylaxis in Patients with Unrecognized Clonal Mast Cell Disorder—Is Mastocytosis to Blame?},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242216368}
}
EUVIMED